POSEIDA THERAPEUTICS INC (PSTX) Stock Analyst Ratings
USA - NASDAQ:PSTX - US73730P1084 - Common Stock
9.5 USD
-0.06 (-0.63%)
9.54 USD
+0.04 (+0.42%)
ChartMill assigns a Buy % Consensus number of 50% to PSTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 9.18. This target is -3.37% below the current price.
PSTX was analyzed by 10 analysts. The buy percentage consensus is at 50. So analysts seem to be rather neutral about PSTX.
In the last month the buy percentage fell by 25 points. So the trust of analysts is decreasing.
PSTX was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-26 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-11-26 | BTIG | Downgrade | Buy -> Neutral |
| 2024-11-26 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-11-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-11 | Piper Sandler | Maintains | Overweight -> Overweight |
| 2023-12-11 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2023-08-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-10 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-23 | HC Wainwright & Co. | Maintains | Buy |
| 2023-02-01 | Cantor Fitzgerald | Reiterate | Overweight |
| 2023-01-04 | HC Wainwright & Co. | Initiate | Buy |
| 2022-08-09 | Piper Sandler | Maintains | Overweight |
| 2022-05-13 | Piper Sandler | Maintains | Overweight |
| 2022-01-07 | Cantor Fitzgerald | Initiate | Overweight |
| 2021-05-18 | BTIG | Initiate | Buy |
POSEIDA THERAPEUTICS INC / PSTX FAQ
What do analysts expect the price target to be for POSEIDA THERAPEUTICS INC (PSTX)?
10 analysts have analysed PSTX and the average price target is 9.18 USD. This implies a price decrease of -3.37% is expected in the next year compared to the current price of 9.5.
What is the consensus rating for POSEIDA THERAPEUTICS INC (PSTX) stock?
The consensus rating for POSEIDA THERAPEUTICS INC (PSTX) is 50 / 100 . This indicates that analysts generally have a neutral outlook on the stock.